Joint conference on the impact of EU legislation on therapeutic advance

authored by

Nikolaus Forgó, Martin Hildebrandt

Abstract

On October 11, 2012, two FP7-funded Research Consortia, CONTRACT (Consent in a Trial and Care Environment) and Academic GMP, held a Joint Conference in Brussels entitled "The Impact of EU Legislation on Therapeutic Advance." Academic researchers including stem cell transplant physicians and cell therapy specialists, legal advocates and representatives from industry, regulatory authorities and patient advocacy groups met with members of the European Parliament and the European Commission. This article summarizes important points of discussion and detailed proposals for improvement.

Organisation(s)

Institute of Legal Informatics

External Organisation(s)

Technical University of Munich (TUM)

Type

Article

Journal

CYTOTHERAPY

Volume

15

Pages

1444-1448

No. of pages

5

ISSN

1465-3249

Publication date

12.2013

Publication status

Published

Peer reviewed

Yes

ASJC Scopus subject areas

Immunology and Allergy, Immunology, Oncology, Genetics(clinical), Cell Biology, Cancer Research, Transplantation

Sustainable Development Goals

SDG 3 - Good Health and Well-being

Electronic version(s)

https://doi.org/10.1016/j.jcyt.2013.06.011 (Access: Closed)